BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11010-022-04389-1.pdf
Reference49 articles.
1. La Vecchia C (2017) Ovarian cancer: epidemiology and risk factors. Eur J Cancer Prev 26(1):55–62
2. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212–236
3. Kossaï M, Leary A, Scoazec JY, Genestie C (2018) Ovarian cancer: a heterogeneous disease. Pathobiology 85(1–2):41–49
4. Gstöttner M, Angerer A, Rosiek R, Bach CM (2012) Quantitative volumetry of cement leakage in viscosity-controlled vertebroplasty. J Spinal Disord Tech 25(5):E150-154
5. Kim A, Ueda Y, Naka T, Enomoto T (2012) Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res 31(1):14
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Naringenin Nanoformulations for Neurodegenerative Diseases;Current Pharmaceutical Biotechnology;2024-12
2. The role of the natural compound naringenin in AMPK-mitochondria modulation and colorectal cancer inhibition;Phytomedicine;2024-08
3. Mechanism of Preventing Recurrence of Stage II-III Colorectal Cancer Metastasiswith Immuno-inflammatory and Hypoxic Microenvironment by a Four IngredientsChinese Herbal Formula: A Bioinformatics and Network Pharmacology Analysis;Current Pharmaceutical Design;2024-07
4. Palm Kernel Cake Extracts Obtained from the Combination of Bacterial Fermentation and Enzymic Hydrolysis Promote Swine Small Intestine IPEC-J2 Cell Proliferation and Alleviate LPS-Induced Inflammation In Vitro;Antioxidants;2024-05-31
5. Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy;Life Science Alliance;2024-02-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3